Literature DB >> 4944746

Antibody to feline oncornavirus-associated cell membrane antigen in neonatal cats.

M Essex, G Klein, S P Snyder, J B Harrold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4944746     DOI: 10.1002/ijc.2910080305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  16 in total

1.  Influence of culture conditions of growth of FL-74 cells and feline oncornavirus cell membrane associated antigen production.

Authors:  R G Olsen; G E Milo; J P Schaller; L E Mathes; L Heding; D S Yohn
Journal:  In Vitro       Date:  1976-01

2.  Naturally occurring persistent feline oncornavirus infections in the absence of disease.

Authors:  M Essex; W D Hardy; S M Cotter; R M Jakowski; A Sliski
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

3.  Transfer and decline of maternal antibody to feline calicivirus.

Authors:  R P Johnson; R C Povey
Journal:  Can Vet J       Date:  1983-01       Impact factor: 1.008

4.  The relation of immune response to pathogenesis, vaccination and epidemiology in virus induced leukaemia.

Authors:  W F Jarrett
Journal:  Br J Cancer Suppl       Date:  1975-03

5.  Feline sarcoma virus induced in vitro progression from premalignant to neoplastic transformation of human diploid cells.

Authors:  G E Milo; R G Olsen; S E Weisbrode; J A McCloskey
Journal:  In Vitro       Date:  1980-09

6.  Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein.

Authors:  J R Stephenson; M Essex; S Hino; W D Hardy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

7.  Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated.

Authors:  E A Hoover; J P Schaller; L E Mathes; R G Olsen
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Cell cycle-dependent intervention by benzamide of carcinogen-induced neoplastic transformation and in vitro poly(ADP-ribosyl)ation of nuclear proteins in human fibroblasts.

Authors:  E Kun; E Kirsten; G E Milo; P Kurian; H L Kumari
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

9.  In vitro activation of feline complement by feline leukemia virus.

Authors:  L Kobilinsky; W D Hardy; R Ellis; S S Witkin; N K Day
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  Protection against feline leukemia by vaccination with a subunit vaccine.

Authors:  M G Lewis; L E Mathes; R G Olsen
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.